Teachers Retirement System of The State of Kentucky Cuts Stock Holdings in Encompass Health Co. (NYSE:EHC)

Teachers Retirement System of The State of Kentucky lowered its position in Encompass Health Co. (NYSE:EHC) by 22.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,006 shares of the company’s stock after selling 13,450 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Encompass Health were worth $4,543,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in EHC. Cetera Advisors LLC bought a new stake in Encompass Health during the first quarter worth $291,000. Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Encompass Health by 13.5% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 7,276 shares of the company’s stock worth $624,000 after buying an additional 866 shares during the last quarter. Oakworth Capital Inc. bought a new position in Encompass Health during the second quarter valued at about $40,000. Raymond James & Associates increased its holdings in Encompass Health by 7.8% during the second quarter. Raymond James & Associates now owns 134,638 shares of the company’s stock worth $11,551,000 after buying an additional 9,701 shares during the last quarter. Finally, Leeward Investments LLC MA raised its position in Encompass Health by 1.2% in the second quarter. Leeward Investments LLC MA now owns 556,625 shares of the company’s stock worth $47,753,000 after acquiring an additional 6,559 shares during the period. 97.25% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on EHC shares. UBS Group raised their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Truist Financial reissued a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Barclays upped their price target on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp lifted their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada boosted their price objective on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $107.11.

Encompass Health Stock Performance

NYSE:EHC opened at $98.19 on Friday. Encompass Health Co. has a 52-week low of $65.33 and a 52-week high of $104.55. The business’s fifty day moving average is $99.35 and its 200 day moving average is $92.49. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a market cap of $9.89 billion, a price-to-earnings ratio of 23.72, a PEG ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.86 earnings per share. Research analysts predict that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. Encompass Health’s payout ratio is currently 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.